Antiviral treatment in outpatients with herps zoster in six major areas of China, 2010-2019
- PMID: 35968424
- PMCID: PMC9372588
- DOI: 10.3389/fpubh.2022.942377
Antiviral treatment in outpatients with herps zoster in six major areas of China, 2010-2019
Abstract
Objective: The objective of this study was to assess the status and trends of antiviral treatment in outpatients with herpes zoster in China.
Methods: Prescription data on antiviral drugs were extracted from the database of the Hospital Prescription Analysis Program of China according to the inclusion criteria. Yearly prescriptions and costs were calculated, and trends were analyzed. The trends were further stratified by age, sex, and specific drug use. The distribution of defined daily costs (DDCs) of valaciclovir and famciclovir were analyzed, and trends in the median DDCs were identified.
Results: A total of 132,911 prescriptions from 49 hospitals located in six major areas of China were included in the analysis. The yearly prescriptions containing antivirals increased from 8,819 in 2010 to 16,361 in 2019. The percentage of prescriptions for patients aged 65 years and above also increased (27.7% in 2010 to 31.0% in 2019), and the number of prescriptions for females was higher than those for males (P < 0.001). The average cost of antivirals per prescription decreased; thus, the yearly cost showed no increasing trend. The main prescribed antivirals were valaciclovir and famciclovir, which progressively increased in prescriptions. The use of acyclovir decreased during the study period. Prescriptions containing topical formulations, acyclovir and penciclovir, both increased. The DDCs of valaciclovir and famciclovir decreased dramatically.
Conclusion: The use of antivirals has increased over the decade, while the cost has not. Antiviral treatments adhere well to recent recommendations, except for the use of topical antivirals. The findings of this study may benefit the healthcare source allocation and management of herpes zoster in China.
Keywords: acyclovir; cost; famciclovir; prescription; valaciclovir.
Copyright © 2022 Yu, Zhao, Jin, Zhu, Yu and Han.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.J Cutan Med Surg. 2003 Sep-Oct;7(5):372-81. doi: 10.1007/s10227-002-0140-3. Epub 2003 Sep 24. J Cutan Med Surg. 2003. PMID: 14505192 Review.
-
Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.Arch Fam Med. 2000 Sep-Oct;9(9):863-9. doi: 10.1001/archfami.9.9.863. Arch Fam Med. 2000. PMID: 11031393 Clinical Trial.
-
New antivirals with activity against varicella-zoster virus.Ann Neurol. 1994;35 Suppl:S69-72. doi: 10.1002/ana.410350720. Ann Neurol. 1994. PMID: 8185303 Review.
-
Efficacy of valacyclovir and famciclovir in herpes zoster: A comparative study.Indian J Pharmacol. 2020 Nov-Dec;52(6):472-475. doi: 10.4103/ijp.IJP_555_18. Indian J Pharmacol. 2020. PMID: 33666187 Free PMC article.
-
Valaciclovir: a review of its use in the management of herpes zoster.Drugs. 2000 Jun;59(6):1317-40. doi: 10.2165/00003495-200059060-00009. Drugs. 2000. PMID: 10882165 Review.
Cited by
-
Patterns and Trends in Pharmacological Treatment for Outpatients with Postherpetic Neuralgia in Six Major Areas of China, 2015-2019.Healthcare (Basel). 2023 Mar 6;11(5):764. doi: 10.3390/healthcare11050764. Healthcare (Basel). 2023. PMID: 36900769 Free PMC article.
-
Prescribing Trends of Fixed-Dose Combination Antibiotics Not Recommended by the WHO (FNRs) for ICU Patients in Six Major Areas of China During a Seven-Year Period.Drug Des Devel Ther. 2024 Dec 6;18:5781-5791. doi: 10.2147/DDDT.S493980. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39664964 Free PMC article.
-
Prevalence and influencing factors of probiotic usage among colorectal cancer patients in China: A national database study.PLoS One. 2023 Sep 21;18(9):e0291864. doi: 10.1371/journal.pone.0291864. eCollection 2023. PLoS One. 2023. PMID: 37733795 Free PMC article.
-
Top 100 Most-Cited Papers in Herpes Zoster from 2000 to 2022: A Bibliometric Study.J Pain Res. 2023 May 29;16:1779-1797. doi: 10.2147/JPR.S409616. eCollection 2023. J Pain Res. 2023. PMID: 37273270 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical